KLKunpeng Li

Kunpeng Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kunpeng Li has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaojian Ji

    Department of Rheumatology, Chinese PLA General Hospital, Beijing, China

    5 shared publications
  • Feng Huang

    Department of Cardiology & Guangxi Key Laboratory Base of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention & Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China

    4 shared publications
  • Anan Wang

    Department of Medical Innovation Research, Chinese PLA General Hospital, Beijing, China

    3 shared publications
  • Jian Zhu

    Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital, Beijing, China

    3 shared publications
  • Jianglin Zhang

    Department of Rheumatology and Immunology The First Medical Center of Chinese PLA General Hospital 28 Fuxing Road, Haidian District Beijing 100853 China 301hospital.com.cn

    3 shared publications
  • Jiawen Hu

    Medical School of Chinese PLA General Hospital, Beijing, China

    3 shared publications

Latest Publications

  • Open Access

    Early diagnosis of axial spondyloarthritis in primary care using multi-agent systems

    by Xiaojian Ji, Zhuofeng Li, Lulu Zeng, Lidong Hu, Yanyan Wang, Kui Zhang, Lianjie Shi, Meng Wei, Lifeng Chen, Lin Guo, et al.

    Axial spondyloarthritis (axSpA) is an inflammatory disease marked by chronic low back pain, with a global average diagnostic delay of 6.7 years. Early diagnosis is crucial for improving prognosis and reducing disability rates, yet primary care physicians (PCPs) may find it challenging to ensure timely recognition and referrals. This study developed and validated Spondyloarthritis Agents (SpAgents), an early diagnostic system based on a multi-agent framework integrating large language models (LLMs) and imaging models. The SpAgents framework includes PlannerAgent, DataAgent, ToolAgent, and DoctorAgent, supported by long-term memory for dynamic knowledge updates. We enrolled 596 patients, dividing 545 from one hospital into a training dataset (n = 359) and a validation dataset (n = 186), along with an independent cohort of 51 patients from five additional hospitals for testing. SpAgents demonstrated strong diagnostic performance, achieving sensitivity of 0.8615 and specificity of 0.8000 during validation, and 0.9375 and 0.7368 during testing. SpAgents exhibited significantly higher sensitivity (0.9400) and accuracy (0.8600) than both PCPs and junior rheumatologists, with overall performance equivalent to that of senior rheumatologists. Under SpAgents-assisted diagnosis, both PCPs and junior rheumatologists showed marked improvements in sensitivity and accuracy. SpAgents effectively enhance early axSpA identification among PCPs, offering an innovative solution to reduce diagnostic delays.


  • From awareness to action: poor knowledge of physical activity correlates with lower activity and worse disease in axial spondyloarthritis

    by Yinan Zhang, Yiwen Wang, Jiawen Hu, Xiaojian Ji, Xingkang Liu, Jiaxin Zhang, Lulu Zeng, Shiwei Yang, Kunpeng Li, Jian Zhu, et al.

    Objective: To investigate the awareness, implementation and factors influencing physical activity (PA) engagement among Chinese patients with radiographic axial spondyloarthritis (r-axSpA), and their relationships with disease status. Methods: This cross-sectional study enrolled 151 r-axSpA patients and evaluated their awareness of PA while collecting sociodemographic and disease-related parameters. PA levels were assessed with the Godin Leisure-Time Exercise Questionnaire (GLTEQ) and daily steps recorded by smartphones. Influencing factors were evaluated using the Inflammatory arthritis FAcilitators and Barriers (IFAB) questionnaire. Spearman's correlation analysis was used to explore relationships between variables. Results: Among 151 r-axSpA patients, 98.0% were aware of health benefits of PA, and 97.4% reported that physicians had recommended PA to them. However, fewer patients knew the World Health Organization recommendations on aerobic PA (33.8%) and muscle-strengthening activities (33.1%), as well as the European League Against Rheumatism (EULAR) recommendations for PA (55.6%). According to daily steps, only 13.2% were classified as active. Individual exercise (62.3%) was the main form. A sedentary group (GLTEQ score < 14) demonstrated significantly poorer awareness of recommendations and higher disease activity compared with a moderately active/active group (GLTEQ score ≥ 14). Awareness of EULAR recommendations was positively correlated with GLTEQ score (P = 0.003). IFAB6 (lack of motivation, P = 0.015) and IFAB8 (knowledge of benefits of PA, P = 0.045) showed significant differences between the sedentary and the moderately active/active group. Conclusion: Despite recognizing health benefits of PA, patients had limited awareness of PA recommendations and under-engaged in PA. This insufficient awareness correlated with lower activity and worse disease status. Healthcare professionals should enhance PA education and encourage regular PA.


  • Open Access

    Assessing and Optimizing Large Language Models on Spondyloarthritis Multi-Choice Question Answering: Protocol for Enhancement and Assessment

    by Anan Wang, Yunong Wu, Xiaojian Ji, Xiangyang Wang, Jiawen Hu, Fazhan Zhang, Zhanchao Zhang, Dong Pu, Lulu Tang, Shikui Ma, et al.

    Background: Spondyloarthritis (SpA), a chronic inflammatory disorder, predominantly impacts the sacroiliac joints and spine, significantly escalating the risk of disability. SpA’s complexity, as evidenced by its diverse clinical presentations and symptoms that often mimic other diseases, presents substantial challenges in its accurate diagnosis and differentiation. This complexity becomes even more pronounced in nonspecialist health care environments due to limited resources, resulting in delayed referrals, increased misdiagnosis rates, and exacerbated disability outcomes for patients with SpA. The emergence of large language models (LLMs) in medical diagnostics introduces a revolutionary potential to overcome these diagnostic hurdles. Despite recent advancements in artificial intelligence and LLMs demonstrating effectiveness in diagnosing and treating various diseases, their application in SpA remains underdeveloped. Currently, there is a notable absence of SpA-specific LLMs and an established benchmark for assessing the performance of such models in this particular field. Objective: Our objective is to develop a foundational medical model, creating a comprehensive evaluation benchmark tailored to the essential medical knowledge of SpA and its unique diagnostic and treatment protocols. The model, post-pretraining, will be subject to further enhancement through supervised fine-tuning. It is projected to significantly aid physicians in SpA diagnosis and treatment, especially in settings with limited access to specialized care. Furthermore, this initiative is poised to promote early and accurate SpA detection at the primary care level, thereby diminishing the risks associated with delayed or incorrect diagnoses. Methods: A rigorous benchmark, comprising 222 meticulously formulated multiple-choice questions on SpA, will be established and developed. These questions will be extensively revised to ensure their suitability for accurately evaluating LLMs’ performance in real-world diagnostic and therapeutic scenarios. Our methodology involves selecting and refining top foundational models using public data sets. The best-performing model in our benchmark will undergo further training. Subsequently, more than 80,000 real-world inpatient and outpatient cases from hospitals will enhance LLM training, incorporating techniques such as supervised fine-tuning and low-rank adaptation. We will rigorously assess the models’ generated responses for accuracy and evaluate their reasoning processes using the metrics of fluency, relevance, completeness, and medical proficiency. Results: Development of the model is progressing, with significant enhancements anticipated by early 2024. The benchmark, along with the results of evaluations, is expected to be released in the second quarter of 2024. Conclusions: Our trained model aims to capitalize on the capabilities of LLMs in analyzing complex clinical data, thereby enabling precise detection, diagnosis, and treatment of SpA. This innovation is anticipated to play a vital role in diminishing the disabilities arising from delayed or incorrect SpA diagnoses. By promoting this model across diverse health care settings, we anticipate a significant improvement in SpA management, culminating in enhanced patient outcomes and a reduced overall burden of the disease. International Registered Report Identifier (IRRID): DERR1-10.2196/57001


  • Open Access

    Assessing and Optimizing Large Language Models on Spondyloarthritis Multi-Choice Question Answering: Protocol for Enhancement and Assessment (Preprint)

    by Anan Wang, Yunong Wu, Xiaojian Ji, Xiangyang Wang, Jiawen Hu, Fazhan Zhang, Zhanchao Zhang, Dong Pu, Lulu Tang, Shikui Ma, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Spondyloarthritis (SpA), a chronic inflammatory disorder, predominantly impacts the sacroiliac joints and spine, significantly escalating the risk of disability. SpA’s complexity, as evidenced by its diverse clinical presentations and symptoms that often mimic other diseases, presents substantial challenges in its accurate diagnosis and differentiation. This complexity becomes even more pronounced in nonspecialist health care environments due to limited resources, resulting in delayed referrals, increased misdiagnosis rates, and exacerbated disability outcomes for patients with SpA. The emergence of large language models (LLMs) in medical diagnostics introduces a revolutionary potential to overcome these diagnostic hurdles. Despite recent advancements in artificial intelligence and LLMs demonstrating effectiveness in diagnosing and treating various diseases, their application in SpA remains underdeveloped. Currently, there is a notable absence of SpA-specific LLMs and an established benchmark for assessing the performance of such models in this particular field. Objective: Our objective is to develop a foundational medical model, creating a comprehensive evaluation benchmark tailored to the essential medical knowledge of SpA and its unique diagnostic and treatment protocols. The model, post-pretraining, will be subject to further enhancement through supervised fine-tuning. It is projected to significantly aid physicians in SpA diagnosis and treatment, especially in settings with limited access to specialized care. Furthermore, this initiative is poised to promote early and accurate SpA detection at the primary care level, thereby diminishing the risks associated with delayed or incorrect diagnoses. Methods: A rigorous benchmark, comprising 222 meticulously formulated multiple-choice questions on SpA, will be established and developed. These questions will be extensively revised to ensure their suitability for accurately evaluating LLMs’ performance in real-world diagnostic and therapeutic scenarios. Our methodology involves selecting and refining top foundational models using public data sets. The best-performing model in our benchmark will undergo further training. Subsequently, more than 80,000 real-world inpatient and outpatient cases from hospitals will enhance LLM training, incorporating techniques such as supervised fine-tuning and low-rank adaptation. We will rigorously assess the models’ generated responses for accuracy and evaluate their reasoning processes using the metrics of fluency, relevance, completeness, and medical proficiency. Results: Development of the model is progressing, with significant enhancements anticipated by early 2024. The benchmark, along with the results of evaluations, is expected to be released in the second quarter of 2024. Conclusions: Our trained model aims to capitalize on the capabilities of LLMs in analyzing complex clinical data, thereby enabling precise detection, diagnosis, and treatment of SpA. This innovation is anticipated to play a vital role in diminishing the disabilities arising from delayed or incorrect SpA diagnoses. By promoting this model across diverse health care settings, we anticipate a significant improvement in SpA management, culminating in enhanced patient outcomes and a reduced overall burden of the disease.

  • Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

    by Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang


  • Open Access

    Systemic lupus erythematosus following human papillomavirus 9-valent vaccination

    by Yuehua Wan, Jinshui Yang, Yurong Zhao, Jingyu Jin, Jian Zhu, Kunpeng Li, Jianglin Zhang

    An abstract is unavailable. This article is available as a PDF only.


  • Open Access

    Improvement of Disease Management and Cost Effectiveness in Chinese Patients with Ankylosing Spondylitis Using a Smart-Phone Management System: A Prospective Cohort Study

    by Xiaojian Ji, Yiwen Wang, Yingpei Ma, Zhengyuan Hu, Siliang Man, Ying Zhang, Kunpeng Li, Jinshui Yang, Jian Zhu, Jianglin Zhang, et al.

    Objectives. Ankylosing spondylitis (AS) is a chronic disease that decreases mobility, function, and quality of life. This study introduced the “Smart-phone SpondyloArthritis Management System” (SpAMS), an interactive mobile health (mHealth) tool designed for AS/spondyloarthritis (SpA) disease management and used SpAMS data to evaluate clinical characteristics of Chinese patients with AS. Methods. SpAMS integrates patient’s and physician’s portals in a smart phone application. The Chinese Ankylosing Spondylitis Prospective Imaging Cohort was launched using SpAMS in April 2016. Patient self-assessments were completed online at baseline and at every subsequent clinic visit. Physician-reported assessments and treatments were recorded by rheumatologists during each visit. Results. In total, 1201 patients with AS [mean (SD) age, 30.6 (8.7) years; male, 82.6%] were recruited. Mean (SD) disease duration was 8.4 (6.1) years. Past or current symptoms of acute anterior uveitis (AAU), psoriasis, and inflammatory bowel disease (IBD) were observed in 21.0%, 3.7%, and 9.4% of patients, respectively. AAU and IBD occurred significantly more in patients with symptom duration > 10 years. The most commonly used medications at baseline were nonsteroidal anti-inflammatory drugs (98.2%). Patients using tumour necrosis factor inhibitors accounted for 20.8%, and 66.4% of patients used conventional synthetic disease-modifying antirheumatic drugs. At baseline, 57.2% of patients had inactive disease (ID)/low disease activity (LDA); this rate significantly improved to 79.2% after a mean follow-up of 13.3 (5.9) months. Compared with relapsed patients, new achievers of ID/LDA underwent more online patient assessments (P < .001). Problems solved in SpAMS caused 29.1% of clinic visits to a tertiary hospital unnecessary. SpAMS saved an average of 5.3 hours and 327.4 RMB per person on traffic expenses; these expenses equalled 16% of the Chinese monthly disposable personal income. Conclusions. SpAMS is a time- and cost-saving disease management tool that can help patients with AS perform self-management and provide valuable data to clinicians.